HUP0002103A3 - Hmg-coa reductase inhibitor preparation process - Google Patents

Hmg-coa reductase inhibitor preparation process

Info

Publication number
HUP0002103A3
HUP0002103A3 HU0002103A HUP0002103A HUP0002103A3 HU P0002103 A3 HUP0002103 A3 HU P0002103A3 HU 0002103 A HU0002103 A HU 0002103A HU P0002103 A HUP0002103 A HU P0002103A HU P0002103 A3 HUP0002103 A3 HU P0002103A3
Authority
HU
Hungary
Prior art keywords
hmg
preparation process
coa reductase
reductase inhibitor
inhibitor preparation
Prior art date
Application number
HU0002103A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Plus Chemicals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plus Chemicals S A filed Critical Plus Chemicals S A
Publication of HUP0002103A1 publication Critical patent/HUP0002103A1/hu
Publication of HUP0002103A3 publication Critical patent/HUP0002103A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0002103A 1997-05-07 1998-05-04 Hmg-coa reductase inhibitor preparation process HUP0002103A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97303111A EP0877089A1 (en) 1997-05-07 1997-05-07 HMG-CoA reductase inhibitor preparation process
PCT/EP1998/002616 WO1998050572A1 (en) 1997-05-07 1998-05-04 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS

Publications (2)

Publication Number Publication Date
HUP0002103A1 HUP0002103A1 (hu) 2000-10-28
HUP0002103A3 true HUP0002103A3 (en) 2001-10-29

Family

ID=8229319

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002103A HUP0002103A3 (en) 1997-05-07 1998-05-04 Hmg-coa reductase inhibitor preparation process

Country Status (7)

Country Link
US (1) US6268186B1 (https=)
EP (2) EP0877089A1 (https=)
JP (1) JP2002510197A (https=)
AU (1) AU7761398A (https=)
HU (1) HUP0002103A3 (https=)
IL (1) IL132786A0 (https=)
WO (1) WO1998050572A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0251582A (ja) * 1988-08-12 1990-02-21 Kyokado Eng Co Ltd 地盤注入用薬液
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
US6372462B2 (en) 1999-10-15 2002-04-16 Medmyco Ltd. Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
CN1468098A (zh) * 2000-10-05 2004-01-14 �ݰ¸Ƕ�ҩ�����޹�˾ 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物
KR100379075B1 (en) * 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
JP3463881B2 (ja) 2002-08-06 2003-11-05 三共株式会社 プラバスタチン又はその薬理上許容される塩の単離・精製方法
JP3422791B2 (ja) 2002-08-06 2003-06-30 三共株式会社 プラバスタチンの単離・精製方法
TW200513539A (en) * 2003-06-09 2005-04-16 Biogal Gyogyszergyar Ion-exchange filtration of fermentation broth
ES2239533B1 (es) * 2004-03-01 2006-12-16 Ercros Industrial, S.A. Procedimiento para la obtencion de compactina.
ATE414071T1 (de) * 2004-03-30 2008-11-15 Lupin Ltd Verbessertes verfahren zur herstellung von 4- hydroxypyran-2-onderivaten
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
US8124096B2 (en) 2006-07-31 2012-02-28 3M Innovative Properties Company Immune response modifier compositions and methods
US20110130450A1 (en) * 2008-04-02 2011-06-02 Aad Johannes Bouman Pravastatin extraction
RU2585234C2 (ru) * 2013-12-27 2016-05-27 Открытое акционерное общество "Красфарма" Способ получения компактина
RU2585233C2 (ru) * 2013-12-27 2016-05-27 Открытое акционерное общество "Красфарма" Промышленный способ получения компактина

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294926A (en) * 1979-06-15 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US4940727A (en) * 1986-06-23 1990-07-10 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
HU208997B (en) * 1992-06-17 1994-02-28 Gyogyszerkutato Intezet Microbiological method for producing mevinoline
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
ATE189804T1 (de) * 1995-08-03 2000-03-15 Dsm Nv Selektives verfahren zur deacylierung von acylverbindungen
US5989877A (en) * 1995-08-03 1999-11-23 Gist-Brocades B.V. Selective process for the deacylation of acylated compounds

Also Published As

Publication number Publication date
JP2002510197A (ja) 2002-04-02
US6268186B1 (en) 2001-07-31
AU7761398A (en) 1998-11-27
EP0980437A1 (en) 2000-02-23
HUP0002103A1 (hu) 2000-10-28
EP0877089A1 (en) 1998-11-11
IL132786A0 (en) 2001-03-19
WO1998050572A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
EP1004669A4 (en) NEW DIFFERENTIATION INHIBITOR
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
HUP0002103A3 (en) Hmg-coa reductase inhibitor preparation process
AU2058992A (en) HMG-COA reductase inhibitors
HUP0100820A3 (en) Process for the obtaining of hmg-coa reductase inhibitors of high purity
AU4543699A (en) Multibinding inhibitors of hmg-coa reductase
AU9443898A (en) Wof inhibitor
AUPP076797A0 (en) Phospholipase inhibitor
AU8997498A (en) Tryptase inhibitor
GB2331357A9 (en) Oven liners
AU5888198A (en) Process for determination of nitrogen
GB2371748B (en) HMG-COA reductase inhibitor extended release formulation
HUP0105145A3 (en) Process for producing hmg-coa reductase inhibitor
HUP0201597A3 (en) Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines
IL132987A0 (en) Method for producing medicaments containing hmg-coa reductase inhibitors
AU6109798A (en) Metal spraying
HUP0105000A3 (en) Process for producing hmg-coa reductase inhibitors
AU5758799A (en) Hmg-coa reductase inhibitor-containing preparations
AU8855298A (en) Iron reductase
EP0468974A4 (en) Novel hmg-coa reductase inhibitors
AU5289398A (en) Steel for cold forming
AU6103599A (en) Packaging of sheet metal coils